Almost a year ago, Life Science Daily News published its first articles with a simple belief. Specialist science deserves a specialist stage. Since then, that belief has grown into a global readership and an active community of contributors. This is the story of our...
FDA Drug Approval Decisions
Last updated 28 October 2026. Covering target action dates from October 2026 to February 2027. October changed how this tracker has to be read. Six FDA drug approval decisions landed in the month, and four arrived ahead of target. One cleared roughly 12 weeks early,...
CRISPR Gene Editing 2026: Rare Diseases, Cancer and Autoimmune
CRISPR gene editing in 2026 is no longer a technology to watch. It is a technology delivering results. Across three distinct disease areas, rare inherited conditions, haematologic and solid cancers, and autoimmune disease, clinical programmes are accumulating...
The GLP-1 Drug Pipeline: Every Candidate to Watch in 2026
The GLP-1 drug pipeline has become one of the most consequential and closely watched in modern pharmaceutical history. In 2026, the class of glucagon-like peptide-1 receptor agonists is no longer defined solely by Ozempic and Wegovy. A new generation of oral tablets,...
Anti-Ro52 vs Anti-Ro60: Advancing Sjögren’s Disease Diagnosis
Autoantibody testing is a central part of autoimmune disease diagnosis, including Sjögren’s disease (SjD). The American College of Rheumatology and European Alliance of Associations of Rheumatology (ACR/EULAR) classification criteria for SjD incorporate ocular and...
Biotech M&A 2026: Every $1B+ Deal so Far and What is Driving Them
Updated 21 October 2026. First published 14 May 2026. Deal values and statuses are as of 21 October 2026. Biopharma M&A 2026 has already outrun last year. J.P. Morgan counts $138.9 billion of upfront M&A across 113 deals by the end of September. That is above...
Biotech M&A 2026: Every $1B+ Deal so Far and What is Driving Them
Updated 21 October 2026. First published 14 May 2026. Deal values and statuses are as of 21 October 2026. Biopharma M&A 2026 has already outrun last year. J.P. Morgan counts $138.9 billion of upfront M&A across 113 deals by the end of September. That is above...
Life Science Daily News: Join the Community
A Community-Driven Hub for Life Sciences News and Discovery In an era of rapid scientific progress and near-constant breakthroughs, having a reliable, inclusive platform to share and explore life-sciences news is more important than ever. Life Science Daily News...
Welcome to Life Science Daily News
Your Gateway to Discovery, Innovation, and Global Scientific Voices In a world where breakthroughs happen every day and scientific understanding is accelerating faster than ever before, Life Science Daily News stands as a vibrant hub for curious minds, passionate...







